Gouji Toyokawa
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 17, 2025
Peribronchial Arteriovenous Malformation with Cowden Syndrome: A Rare Case Report.Shuta Sumitomo, Gouji Toyokawa, Yue Cong
|Jun 26, 2021
Association between pretreatment neutrophil-to-lymphocyte ratio and immune-related adverse events due to immune checkpoint inhibitors in patients with non-small cell lung cancer.Airi Fujimoto, Gouji Toyokawa, Yoshimichi Koutake
|May 03, 2021
ALK-positive lung cancer in a patient with recurrent brain metastases and meningeal dissemination who achieved long-term survival of more than seven years with sequential treatment of five ALK-inhibitors: A case report.Keisuke Yamamoto, Gouji Toyokawa, Yuka Kozuma
|Aug 26, 2020
Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease-free survival in individuals with non-small cell lung cancer.Nobuhisa Ando, Kentaro Tanaka, Kohei Otsubo
|Jul 25, 2019
Short progression-free survival of ALK inhibitors sensitive to secondary mutations in ALK-positive NSCLC patients.Naoki Haratake, Takashi Seto, Shinkichi Takamori
|Aug 07, 2018
Significance of spread through air spaces in early-stage lung adenocarcinomas undergoing limited resection.Gouji Toyokawa, Yuichi Yamada, Tetsuzo Tagawa
Pageof 1
